Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.

Suppr

超能文献

作者信息

Thorsen S

出版信息

Dan Med Bull. 1977 Oct;24(5):189-206.

PMID:908205

Abstract

摘要

相似文献

Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.

Dan Med Bull. 1977 Oct;24(5):189-206.

Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.底物组成及ε-氨基己酸对组织型纤溶酶原激活物和尿激酶诱导的纤维蛋白溶解的影响。

Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):306-24.

Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.组织型纤溶酶原激活剂与尿激酶在体外的相对纤维蛋白溶解、纤溶及溶栓特性比较

Thromb Haemost. 1981 Jun 30;45(3):225-9.

Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).

Thromb Diath Haemorrh. 1975 Sep 30;34(1):351.

Differences in the reactivities of human urokinase and the porcine tissue plasminogen activator.

Haemostasis. 1976;5(5):295-305. doi: 10.1159/000214148.

[Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].[使用组织型纤溶酶原激活剂和尿激酶原进行溶栓：协同作用；突变体和杂交体]

Sangre (Barc). 1989 Aug;34(4):297-9.

Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.组织型纤溶酶原激活剂（t-PA）与单链尿激酶型纤溶酶原激活剂（scu-PA）在体外对血凝块溶解的协同作用及其作用机制。

Thromb Haemost. 1987 Jun 3;57(3):372-3.

[Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].[生理激活剂和真菌源酶作用诱导动物纤维蛋白溶解系统成分的变化]

Nauchnye Doki Vyss Shkoly Biol Nauki. 1983(3):51-4.

Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.与抗纤维蛋白抗体偶联的单链尿激酶型纤溶酶原激活剂（scuPA）增强血浆和体内的溶栓作用。

Trans Assoc Am Physicians. 1989;102:7-12.

Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.组织型纤溶酶原激活剂（t-PA）和单链尿激酶型纤溶酶原激活剂（scu-PA）：纤维蛋白特异性溶栓治疗的潜力。

Prog Hemost Thromb. 1986;8:1-18.

引用本文的文献

Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).动脉瘤性蛛网膜下腔出血后血液和脑脊液中的凝血与纤溶：氨甲环酸（AMCA）的作用

Acta Neurochir (Wien). 1981;56(1-2):25-38. doi: 10.1007/BF01400969.

Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.培养的牛内皮细胞可产生尿激酶和组织型纤溶酶原激活剂。

J Cell Biol. 1982 Sep;94(3):631-6. doi: 10.1083/jcb.94.3.631.

Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.谷氨酸纤溶酶、赖氨酸纤溶酶和微型纤溶酶与纤维蛋白的次要位点结合。

Biochem J. 1981 Sep 1;197(3):619-28. doi: 10.1042/bj1970619.

Fibrinolysis in cornea and conjunctiva: evidence of two types of activators.

Graefes Arch Clin Exp Ophthalmol. 1986;224(5):393-6. doi: 10.1007/BF02173351.

Clinical application of inhibitors of fibrinolysis.纤维蛋白溶解抑制剂的临床应用。

Drugs. 1985 Mar;29(3):236-61. doi: 10.2165/00003495-198529030-00003.

Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth.纤溶酶原激活可改变静止的3T3细胞单层的形态并启动生长。

Br J Cancer. 1979 Jun;39(6):718-30. doi: 10.1038/bjc.1979.126.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验